Skye Bioscience, Inc. (SKYE) KPIs and segments

SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30

$1.09+0.01 (+0.93%)

Close on Nov 13, 2026Market cap $4.82MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Skye Bioscience's business

Coming soon

This tab will track the numbers specific to Skye Bioscience's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?